Serum NfL levels are a non‐specific biomarker of neuronal injury and are elevated in several neurological disorders, including amyotrophic lateral sclerosis (ALS)5 and multiple sclerosis (MS).6 Here, NEFL is linked to amyotrophic lateral sclerosis.